Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 2 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
sara merli[Author]
(7 results)?
Identifying a selective inhibitor of autophagy that targets ATG12-ATG3 protein-protein interaction.
Autophagy. 2023 Aug;19(8):2372-2385. doi: 10.1080/15548627.2023.2178159. Epub 2023 Feb 22.
Autophagy. 2023.
PMID: 37184247
Free PMC article.
DAP5 drives translation of specific mRNA targets with upstream ORFs in human embryonic stem cells.
David M, Olender T, Mizrahi O, Weingarten-Gabbay S, Friedlander G, Meril S, Goldberg N, Savidor A, Levin Y, Salomon V, Stern-Ginossar N, Bialik S, Kimchi A.
David M, et al. Among authors: meril s.
RNA. 2022 Oct;28(10):1325-1336. doi: 10.1261/rna.079194.122. Epub 2022 Aug 12.
RNA. 2022.
PMID: 35961752
Free PMC article.
Item in Clipboard
Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells.
Meril S, Harush O, Reboh Y, Matikhina T, Barliya T, Cohen CJ.
Meril S, et al.
Mol Carcinog. 2020 Jul;59(7):713-723. doi: 10.1002/mc.23213. Epub 2020 May 11.
Mol Carcinog. 2020.
PMID: 32391973
Item in Clipboard
Loss-of-function cancer-linked mutations in the EIF4G2 non-canonical translation initiation factor.
Meril S, Bahlsen M, Eisenstein M, Savidor A, Levin Y, Bialik S, Pietrokovski S, Kimchi A.
Meril S, et al.
Life Sci Alliance. 2023 Dec 21;7(3):e202302338. doi: 10.26508/lsa.202302338. Print 2024 Mar.
Life Sci Alliance. 2023.
PMID: 38129098
Free PMC article.
Item in Clipboard
Loss of EIF4G2 mediates aggressiveness in distinct human endometrial cancer subpopulations with poor survival outcome in patients.
Meril S, Muhlbauer Avni M, Lior C, Bahlsen M, Olender T, Savidor A, Krausz J, Belhanes Peled H, Birisi H, David N, Bialik S, Scherz-Shouval R, Ben David Y, Kimchi A.
Meril S, et al.
Oncogene. 2024 Feb 22. doi: 10.1038/s41388-024-02981-x. Online ahead of print.
Oncogene. 2024.
PMID: 38388710
Item in Clipboard
Cite
Cite